I read an article at the end of September that brought my attention to a small-cap growth fund managed by M&I Asset Management, a Milwaukee-based firm that's now part of the Bank of Montreal (NYSE:BMO). The Marshall Small-Cap Growth Fund (MRSCX) has more than doubled investors' money over the past 10 years. The fund's third largest holding is Safeguard Scientifics (NYSE:SFE), a hybrid between a venture capital and a private equity, that invests in growth-stage life sciences and technology businesses. Despite a checkered past, its future is bright. Read on and I'll explain why.

Investopedia Markets: Explore the best one-stop source for financial news, quotes and insights.

Experience
Safeguard's past goes all the way back to 1953 when Warren "Pete" Musser and Frank Diamond created Lancaster Corporation, a holding company that would invest in small firms like Safeguard Corporation, a manufacturer of bookkeeping and accounting products. Its investment in Safeguard was so successful that it spun off the business into its own independent company in 1980. One year later, Lancaster was renamed Safeguard Scientifics. At the height of the dot-com boom, Safeguard Scientifics' market cap was as high as $6.9 billion, very different from the $325 million today. After the 2000 crash, its market cap went into the tank, and eventually it replaced Musser in October 2001 with Anthony Craig, who stabilized its business over three years. Then, in 2005, Craig stepped aside for its current CEO, Peter Boni, who came over from private equity firm, Advent International. Boni and his team have turned things around and in recognition of their achievement, Ernst & Young named Boni one of Philadelphia's Entrepreneurs of the Year. It's on a roll.

Investments
The first thing Boni did, upon his arrival, was to sell many of Safeguard's existing investments and redeploy the funds in early-stage companies in both tech and life sciences. In the past year, four of its portfolio companies have sold for $1.72 billion, with performance clauses that could take the number as high as $2.23 billion. If so, it would receive $431 million for its trouble, an average return of between three and 13 times its original investment. Its current roster of companies is 13, seven in life sciences and six in technology. However, two are public: NuPathe (Nasdaq:PATH), a specialty pharmaceutical company with an 18% interest, and Tengion (Nasdaq:TNGN), an organ regeneration business with a 2.5% interest. Patrick Gundlach, the co-manager of the Marshall fund, particularly likes the fact that its investments were able to grow revenues from $100 million in 2007 to $400 million in 2010, suggesting more paydays are on the horizon. (For more on this industry, read The Ups And Downs Of Biotechnology.)

Cash
The hard part for Safeguard is redeploying cash from its successful exits. Safeguard has $254 million in cash on its books, as of the end of June, and only $45 million in debt, although the interest rate is relatively high at 10.125%. It could pay down the debt, but investments with this kind of risk profile do warrant a higher yield. Therefore, it will have to find some new investments to go along with the existing ones. In July, it acquired 36% of Penn Mezzanine, a mezzanine lender for companies with revenues between $5 million and $100 million and a history of profitability. Safeguard paid $3.7 million for its stake, and will commit and an additional $26.4 million to future Penn Mezzanine funds. It made the investment to provide a stable stream of income while it redeploys capital. Some analysts don't like the move because the middle-market is a competitive racket. I don't see a problem with it because Penn tends to target smaller companies, which are definitely underserved.

The Bottom Line
Safeguard's share price as of October 17 was $15.73. Its cash per share is $12.31. You're buying a piece of 13 investments for $3.42 a share. If one or two of those investments end up being acquired, you'll get your money back, and then some. I wouldn't bet the farm, but the risk is manageable and the rewards tremendous.

Use the Investopedia Stock Simulator to trade the stocks mentioned in this stock analysis, risk free!

Related Articles
  1. Entrepreneurship

    Top 5 Startups that Emerged in London

    Learn why London's startup scene is so prolific, and identify some of the hottest companies emerging from this scene as of mid-2015.
  2. Stock Analysis

    Net Neutrality: Pros and Cons

    The fight over net neutrality has become an amazing spectacle. But at its core, it's yet another skirmish in cable television's war to remain relevant.
  3. Active Trading Fundamentals

    The Companies of Peter Theil's Founders Fund

    Learn about the major public companies that Peter Thiel has invested in and companies that are on the verge of going public at multibillion-dollar valuations.
  4. Personal Finance

    A Day in the Life of an Equity Research Analyst

    What does an equity research analyst do on an everyday basis?
  5. Mutual Funds & ETFs

    ETF Analysis: PowerShares S&P 500 Downside Hedged

    Find out about the PowerShares S&P 500 Downside Hedged ETF, and learn detailed information about characteristics, suitability and recommendations of it.
  6. Mutual Funds & ETFs

    ETF Analysis: ProShares Large Cap Core Plus

    Learn information about the ProShares Large Cap Core Plus ETF, and explore detailed analysis of its characteristics, suitability and recommendations.
  7. Mutual Funds & ETFs

    ETF Analysis: iShares Core Growth Allocation

    Find out about the iShares Core Growth Allocation Fund, and learn detailed information about its characteristics, suitability and recommendations.
  8. Mutual Funds & ETFs

    ETF Analysis: iShares MSCI USA Minimum Volatility

    Learn about the iShares MSCI USA Minimum Volatility exchange-traded fund, which invests in low-volatility equities traded on the U.S. stock market.
  9. Stock Analysis

    Should You Follow Millionaires into This Sector?

    Millionaire investors—and those who follow them—should take another look at the current economic situation before making any more investment decisions.
  10. Professionals

    What to do During a Market Correction

    The market has corrected...now what? Here's what you should consider rather than panicking.
RELATED TERMS
  1. Equity

    The value of an asset less the value of all liabilities on that ...
  2. Venture Capitalist

    An investor who either provides capital to startup ventures or ...
  3. Path To Profitability (P2P)

    A clearly defined route to profitability as described in a business ...
  4. Hard-To-Sell Asset

    An asset that is extremely difficult to dispose of either due ...
  5. Sucker Yield

    When an investor has essentially risked all of his capital for ...
  6. PT (Perseroan Terbatas)

    An acronym for Perseroan Terbatas, which is Limited Liability ...
RELATED FAQS
  1. How do dividends affect retained earnings?

    When a company issues a cash dividend to its shareholders, the retained earnings listed on the balance sheet are reduced ... Read Full Answer >>
  2. What is the difference between called-up share capital and paid-up share capital?

    The difference between called-up share capital and paid-up share capital is investors have already paid in full for paid-up ... Read Full Answer >>
  3. Why would a corporation issue convertible bonds?

    A convertible bond represents a hybrid security that has bond and equity features; this type of bond allows the conversion ... Read Full Answer >>
  4. How does additional paid in capital affect retained earnings?

    Both additional paid-in capital and retained earnings are entries under the shareholders' equity section of a company's balance ... Read Full Answer >>
  5. What types of capital are not considered share capital?

    The money a business uses to fund operations or growth is called capital, and there are a number of capital sources available. ... Read Full Answer >>
  6. What is the difference between issued share capital and subscribed share capital?

    The difference between subscribed share capital and issued share capital is the former relates to the amount of stock for ... Read Full Answer >>

You May Also Like

COMPANIES IN THIS ARTICLE
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!